
|Articles|July 18, 2016
Case 2: Same patient with more severe DME and history of cardiovascular events
Hear about the case, view the slides, and vote on your responses.
Advertisement
Download all slides for case 2,
Download all slides for case 2,
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
What ‘I’m Fine’ Really Means: An Open Letter from a Thyroid Eye Disease (TED) Patient
2
PolyActiva and RareSight partner to develop treatments for rare pediatric retinal diseases
3
Q&A: Advancing a long-acting anti-VEGF candidate: What it means for retinal disease
4
Opus Genetics has Type B RMAT meeting with FDA for its gene therapy candidate, OPGx-LCA5
5


















































.png)


